News

More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an ...
Ro Khanna announced plans to introduce legislation to codify the president's directive aimed at lowering prescription drug ...
In this week’s edition of InnovationRx, we look at Trump's drug pricing executive order, how the cofounder of Hims became a ...
Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...
This is misleading. Prices for most prescription drugs — unbranded generics are the exception — are higher in the U.S. than ...
Toward the end of his first Administration, Trump signed a similar Executive Order aimed at lowering the prices of some drugs ...
President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit ...
U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...
The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...
President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United States — but why are drugs so high to begin with?
Seoul: Celltrion, a leading South Korean biopharmaceutical company, on Thursday said its business will remain largely ...